Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

CHWY Stock Up 13% Following Solid Q4 Performance Despite Earnings Miss
CHWY Stock Up 13% Following Solid Q4 Performance Despite Earnings Miss

Chewy, Inc. CHWY reported solid fourth-quarter fiscal 2025 results, wherein the top line beat the Zacks Consensus Estimate and the bottom line missed the same. Also, sales increased and earnings

Norwegian Cruise Line Holdings Ltd. (NCLH) is Attracting Investor Attention: Here is What You Should Know
Norwegian Cruise Line Holdings Ltd. (NCLH) is Attracting Investor Attention: Here is What You Should Know

Norwegian Cruise Line (NCLH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of

Why Norwegian Cruise Line (NCLH) Dipped More Than Broader Market Today
Why Norwegian Cruise Line (NCLH) Dipped More Than Broader Market Today

Norwegian Cruise Line (NCLH) closed at $19.85 in the latest trading session, marking a -1.83% move from the prior day. This move lagged the S&P 500's daily loss of 1.74%. Meanwhile, the Dow lost

ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) came out with a quarterly loss of $0.42 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.52 per share a year ago. These figures

Acco Brands (ACCO) Matches Q4 Earnings Estimates
Acco Brands (ACCO) Matches Q4 Earnings Estimates

Acco Brands (ACCO) came out with quarterly earnings of $0.38 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.39 per share a year ago. These figures are

AIZ Stock Trading at a Discount to Industry at 1.9X: Time to Hold?
AIZ Stock Trading at a Discount to Industry at 1.9X: Time to Hold?

Assurant, Inc. AIZ shares are trading at a discount compared with the Zacks Multi-line Insurance industry. Its forward price-to-book value of 1.9X is lower than the industry average of 2.25X, the Fi

Will Weak Gardasil Sales Continue to Weigh on MRK's Top Line in 2026?
Will Weak Gardasil Sales Continue to Weigh on MRK's Top Line in 2026?

Merck MRK continues to face challenges with its second-largest product, Gardasil, which is a vaccine approved to prevent certain cancers caused by the human papillomavirus. While the vaccine’s sales

Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study
Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study

Roche RHHBY announced results from a late-stage study evaluating its investigational candidate, giredestrant, in combination with palbociclib for patients with estrogen receptor (ER)-positive, human

Canadian Natural Q4 Earnings Beat Estimates, Expenses Decrease Y/Y
Canadian Natural Q4 Earnings Beat Estimates, Expenses Decrease Y/Y

Canadian Natural Resources Limited CNQ reported fourth-quarter 2025 adjusted earnings per share of 59 cents, which beat the Zacks Consensus Estimate of 53 cents. However, the bottom line decreased

Should Investors Buy Old Dominion Stock Post Dividend Hike?
Should Investors Buy Old Dominion Stock Post Dividend Hike?

Last month, Old Dominion Freight Line, Inc. (ODFL) stated that its board of directors had announced an increase in its quarterly dividend payout, reflectingthe company’s commitment to boosting

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates

Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.09 per share a year ago. These figures are adjusted

Custom Truck One Source, Inc. (CTOS) Matches Q4 Earnings Estimates
Custom Truck One Source, Inc. (CTOS) Matches Q4 Earnings Estimates

Custom Truck One Source, Inc. (CTOS) came out with quarterly earnings of $0.09 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.04 per share a year ago. These

Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates
Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates

Exagen Inc. (XGN) came out with a quarterly loss of $0.2 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.2 per share a year ago. These figures are adjusted for

Petrobras Q4 Earnings Beat as Output Growth Offsets Oil Drop
Petrobras Q4 Earnings Beat as Output Growth Offsets Oil Drop

Petroleo Brasileiro S.A., or Petrobras PBR, posted fourth-quarter earnings per ADS of 72 cents, beating the Zacks Consensus Estimate of 57 cents. The bottom line improved from the year-ago profit of

AEG or PUK: Which Is the Better Value Stock Right Now?
AEG or PUK: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Insurance - Multi line sector have probably already heard of Aegon NV (AEG) and Prudential (PUK). But which of these two stocks presents investors with the

GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma
GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma

GSK plc GSK signed a license agreement with Italy-based Alfasigma. Per the terms of the agreement, Alfasigma has acquired exclusive global rights from GSK to develop and market linerixibat, an

XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study
XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study

Shares of Xenon Pharmaceuticals XENE surged 49.6% yesterday after the company announced positive top-line data from the phase III X-TOLE2 study, which evaluated its lead pipeline candidate

Recurring Contracts & Solid Liquidity Aid Booz Allen Amid Rising Costs
Recurring Contracts & Solid Liquidity Aid Booz Allen Amid Rising Costs

Booz Allen Hamilton’s BAH top line is gaining from long-term government contracts, providing steady revenues and offsetting market volatility. The company’s strong strategies improve operational

Vail Resorts Q2 Earnings and Revenues Miss Estimates, Guidance Lowered
Vail Resorts Q2 Earnings and Revenues Miss Estimates, Guidance Lowered

Vail Resorts, Inc. MTN reported dismal second-quarter fiscal 2026 results, with earnings and revenues missing the Zacks Consensus Estimate. On a year-over-year basis, both the top and bottom lines

Groupon (GRPN) Q4 Earnings Meet Estimates
Groupon (GRPN) Q4 Earnings Meet Estimates

Groupon (GRPN) came out with quarterly earnings of $0.17 per share, in line with the Zacks Consensus Estimate . This compares to a loss of $1.2 per share a year ago. These figures are adjusted for